Early low-dose aspirin after clot-busting stroke treatment
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether taking aspirin early (within 24 hours) after receiving clot-busting medication for a stroke helps prevent another stroke. You'll receive the standard clot-busting treatment, then take low-dose aspirin to see if it improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Receive clot-busting medication (rt-PA) within 3 hours of stroke symptoms starting
- Have stroke symptoms (like weakness or speech problems) lasting more than 1 hour
- CT scan confirms stroke (not bleeding) with no brain changes explaining your symptoms
- Be able to swallow and take medicine by mouth
- Not currently taking blood thinners like warfarin or other anticoagulants
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
This trial compares two ways to treat a minor acute ischemic stroke: aspirin plus clopidogrel versus an IV clot-busting medicine (alteplase). It aims to see which approach works better and is safer when symptoms start within 4.5 hours.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
This trial tests if giving a second dose of a clot-busting drug (tenecteplase) helps people who had a stroke and didn't improve much after the first dose. You must receive the second dose within 4.5 hours of your stroke symptoms starting.
This study tests whether giving a clot-busting medicine through an IV can help people who have had a stroke while taking a common blood thinner (apixaban, dabigatran, edoxaban, or rivaroxaban). It may be an option if your last dose of the blood thinner was 12 to 48 hours before the stroke and you arrive at the hospital within 4.5 hours of symptoms starting.
Hear when a new Cerebral Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.